Pradaxa Maker Boehringer Ingelheim Pharmaceuticals Pursues Pradaxa FDA Approval to treat DVT and PE

Legal-Bay, Lawsuit Money Advance Firm, says Boehringer submitted a supplemental new drug application to the FDA for Pradaxa so it can be used to treat the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone a primary elective total hip replacement surgery.

Apr 21, 2015, 05:00 ET from Legal-Bay LLC

LOS ANGELES, April 21, 2015 /PRNewswire/ -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that Pradaxa's maker, Boehringer Ingelheim Pharmaceuticals, is seeking FDA approval for its blood thinner to treat DVT and PE. According to PBR, Boehringer submitted a supplemental new drug application (sNDA) to the FDA in hopes that Pradaxa will be approved for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) for patients who have undergone a primary elective total hip replacement surgery (Legal-Bay also assists patients with DePuy, Stryker, Biomet hip lawsuit funding and assistance with finding a hip recall law firm). If the FDA approves the Pradaxa request, this will be the fourth indication for Pradaxa.

Logo - http://photos.prnewswire.com/prnh/20140714/126845

Boehringer Ingelheim reached a $650 million settlement in May of 2014 over their blood thinner, Pradaxa, on approximately 4,000 cases filed in state and federal courts (In re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation, case number 3:12-md-02385, in the U.S. District Court for the Southern District of Illinois). The lawsuits alleged that Pradaxa may cause bleeding events to occur which cannot be controlled and may even be fatal. The Federal Pradaxa lawsuits were consolidated into multidistrict litigation in the U.S. District Court for the Southern District of Illinois under Judge David R. Herndon in August of 2012 and the settlement was reached in May of 2014. Despite agreeing to the settlement, Boehringer Ingelheim denied any misconduct or unlawful activity, stating that they believed the settlement allows their company "to avoid the distraction and uncertainty of protracted litigation over years and years."

Since the Pradaxa litigation settlement, now a new blood thinner, Xarelto, is also the target of lawsuit claims being filed in both state and federal courts for similar injuries (In Re: Xarelto Products Liability Litigation, No. 2592). The Pradaxa settlement value was approximately $160K average per case; plaintiff attorneys close to the litigation believe that Xarelto cases could see similar settlement amounts if the plaintiffs can prove their cases in a court of law. Xarelto's maker, Bayer and Johnson & Johnson's Janssen Pharmaceutical Division, continue to fight the suits. 

Chris Janish, CEO of Legal-Bay, commented on the recent news on the blood thinner drugs, "We are seeing that the blood thinner drug market continues to expand with requests for additional FDA approvals, even while settlements have been announced for large amounts in the Pradaxa litigation, and new cases are being filed every day in the Xarelto litigation. We understand the need for some of these drugs in the market, however, we continue to support and assist patients who are in need of lawsuit funding services or help with finding a qualified blood thinner attorney."     

Legal-Bay, a lawsuit money advance firm, is urging users of Pradaxa and/or Xarelto or family members who have had a loved one injured or deceased from their use of Pradaxa or Xarelto to contact a Pradaxa or Xarelto law firm immediately. Legal-Bay works with nationally recognized Pradaxa and Xarelto lawyers and attorneys who can assist you with obtaining a free legal consultation on your potential lawsuit claim. To learn more about Legal Bay's blood thinner cash advance programs, including how to receive up to a $50K advance right now on your Pradaxa settlement, visit: http://lawsuitssettlementfunding.com/pradaxa-settlement-funding.php

Legal-Bay's funding programs are non-recourse lawsuit cash advances, also known as case funding. None of the programs should be considered to be a settlement loan, settlement loans, lawsuit loan, lawsuit loans, pre-settlement loans, or a pre-settlement loan.

If you, or a loved one, are in need of lawsuit pre-settlement or settlement funding, or you would like to speak with a Pradaxa or Xarelto lawyer or law firm, feel free to contact Legal-Bay on their 24-hour toll-free hotline at: 877.571.0405. Live agents are standing by to assist you with whatever questions you may have. Or, you may fill out an online application to receive a free evaluation on your case at: http://lawsuitssettlementfunding.com

Legal-Bay LLC (and their related companies) is not a law firm and cannot provide legal advice on a consumer's case; however, Legal-Bay works with lawyers involved in mass tort litigations who can provide a free legal consultation at the consumer's direction.



Contact:

Patty Kirby, COO/Head of Client Relations


Ph. 877.571.0405 Email: intake@legal-bay.com



 

SOURCE Legal-Bay LLC



RELATED LINKS

http://www.legal-bay.com